NCT00913458

Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis

A 3-Phase Study to Evaluate Sustained Remission and Productivity Outcomes in Subjects With Early Rheumatoid Arthritis Initiated on Treatment With Etanercept Plus Methotrexate

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 306 (actual)
• Sponsor: Pfizer · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Study to evaluate whether there is sustained remission and productivity in subjects with early rheumatoid arthritis started on etanercept plus methotrexate treatment.

Conditions

• Active Rheumatoid Arthritis
• Arthritis, Rheumatoid
• Rheumatoid Arthritis

Interventions

Type	Name	Description
DRUG	etanercept

Timeline

• Start date: 2009-09-01
• Primary completion: 2012-06-01
• Completion: 2012-12-01
• First posted: 2009-06-04
• Last updated: 2014-07-17
• Results posted: 2014-07-17

Locations

59 sites across 13 countries: France, Germany, Ireland, Italy, Monaco, Netherlands, Poland, Qatar, Romania, Russia, Spain, Switzerland, United Kingdom